FDA — authorised 8 September 1948
- Application: ANDA060734
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Local brand name: BACIGUENT
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
🇺🇸 2% mupirocin ointment in United States
FDA authorised 2% mupirocin ointment on 8 September 1948
Marketing authorisations
FDA — authorised 9 November 1971
- Application: ANDA061212
- Marketing authorisation holder: PADAGIS US
- Local brand name: BACITRACIN
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
FDA — authorised 6 January 1972
- Application: ANDA061580
- Marketing authorisation holder: X GEN PHARMS
- Local brand name: BACI-RX
- Indication: POWDER — FOR RX COMPOUNDING
- Status: approved
FDA — authorised 21 December 1972
- Application: ANDA061699
- Marketing authorisation holder: APOTHEKERNES
- Local brand name: BACITRACIN
- Indication: POWDER — FOR RX COMPOUNDING
- Status: approved
FDA
- Application: ANDA062158
- Marketing authorisation holder: PHARMADERM
- Local brand name: BACITRACIN
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
FDA
- Application: NDA050598
- Marketing authorisation holder: COMBE
- Local brand name: LANABIOTIC
- Indication: DISC — TOPICAL
- Status: approved
FDA
- Application: ANDA061048
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Local brand name: MYCITRACIN
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
FDA
- Application: ANDA062857
- Marketing authorisation holder: NASKA
- Local brand name: BACITRACIN
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA
- Application: ANDA062696
- Marketing authorisation holder: QUAD PHARMS
- Local brand name: BACITRACIN
- Indication: Injectable — Injection
- Status: approved
FDA
- Application: ANDA060687
- Marketing authorisation holder: LILLY
- Local brand name: BACITRACIN
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
FDA
- Status: approved
2% mupirocin ointment in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is 2% mupirocin ointment approved in United States?
Yes. FDA authorised it on 8 September 1948; FDA authorised it on 9 November 1971; FDA authorised it on 6 January 1972.
Who is the marketing authorisation holder for 2% mupirocin ointment in United States?
PHARMACIA AND UPJOHN holds the US marketing authorisation.